|
Mobile version
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ankle sprains hit male athletes hardest Reuters Share     A new study in West Point cadets sheds a bit more light on risk factors for two relatively rare, but severe, types of ankle sprain. So-called "high" and "inner" ankle sprains account for 10 to 15 percent of all ankle sprains, Dr. Brett D. Owens of Keller Army Hospital in West Point, N.Y., and his colleagues note in the American Journal of Sports Medicine. Both types of sprain result in longer time lost due to injury and greater disability than more common sprains. More
No final stretch in plantar fasciitis debate Lower Extremity Review Share
The extent to which stretching and strengthening exercises successfully address plantar fasciitis continues to be a matter of debate among practitioners. Variables known to be associated with the condition include obesity, reduced ankle dorsiflexion, and work-related weight-bearing. A 2008 study in Skeletal Radiology, however, added atrophy of the abductor digiti minimi muscle to the list, although it remains unclear whether the atrophy was the cause of fasciitis or its result. More Orthotics work in mysterious ways CMAJ Share
Most drivers don't think much about spark plugs and carburetors. They just want their vehicles to run, leaving the details to their mechanics. Most homeowners trust electricians to worry about voltages and alternating currents. They just want their lights to come on. In the same way, most patients who use medical devices just want the devices to work. Knowing how they work is the domain of clinicians and researchers. Unless, that is, the medical device is a foot orthotic. According to Benno Nigg, professor of biomechanics and co-director of the Human Performance Laboratory at the University of Calgary in Alberta, even medical experts aren't sure exactly how orthotics relieve pain or prevent injury. "Orthotics can work and can have fantastic effects, but we don’t know how they work," says Nigg. More
Meet Dr. Jeffrey Ross - today at 9 p.m. EST ACFAOM Share
Jeffrey Ross, DPM, M.D., will be the guest on today's Meet the Masters audio-conference (at 9 p.m. EST) with host, and former ACFAOM president, Dr. Bret Ribotsky. Dr. Ross is a well-known podiatric sports medicine authority. To register for this FREE weekly, and unique, learning experience that will give you additional insights into the profession's past and future click here. More MACI may be safe for osteochondral ankle lesions ORTHOSuperSite Share
Arthroscopic matrix-associated chondrocyte implantation for osteochondral ankle lesions is safe and offers good overall clinical and magnetic resonance imaging results, according to these results. Matthias Aurich, M.D., of University Hospital in Jena, Germany, and colleagues performed a clinical and MRI review of 18 patients who had a total of 19 osteochondral ankle lesions and were treated with arthroscopic matrix-associated chondrocyte implantation (MACI) between February 2006 and May 2008. More Report: Shaking shoes good for diabetics The Nation Share
Vibrating insoles can improve balance in patients with stroke or diabetic neuropathy, a common nerve problem that affects sensation in the feet and elsewhere, Boston researchers report. The vibration, adjusted to a sub-sensory level, appears to "tickle" neurons, making them more sensitive to stimuli that are present during standing, Dr. James Collins of Boston University, said. Collins and his team had previously shown that sub-sensory mechanical noise delivered to the feet via the insoles could help people maintain better balance. More
Sanofi-aventis, Sunnybrook to jointly develop diabetic foot ulcer treatment Pharmaceutical Business-Review Share
Sanofi-aventis and Toronto-based Sunnybrook Health Sciences Centre have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds such as neuropathic and neuroischemic diabetic foot ulcers. Vasculotide is a synthetic peptide-based growth factor which targets Tie2, a receptor on specialized cells of the hematopoietic and vascular systems. Vasculotide was invented by Sunnybrook Research Institute scientists Dan Dumont and Paul Van Slyke. More Study shows extended-release anesthetic is safe, effective The San Diego Union-Tribune Share
An experimental extended-release version of a government-approved local anesthetic showed effectiveness and safety in a Phase 3 clinical trial of patients recovering from bunion surgery, said Pacira Pharmaceuticals, which has its main operations in San Diego. Patients receiving Exparel required significantly fewer pain pills than those who got a placebo and provided pain relief for at least 48 hours, researchers said during the annual meeting of the American Academy of Orthopedic Surgeons in San Diego. More
CDC survey will review physician adoption of EMRs FierceEMR Share
In its annual National Ambulatory Medical Care Survey, the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC) will be sending nearly 5,500 physicians a supplemental survey to measure the adoption and impact of electronic medical records (EMRs) in their practices. The survey reviews office visits made by ambulatory patients to non-Federal office-based physicians (excluding those in the specialties of anesthesiology, radiology, and pathology) who are engaged in direct patient care. More House blocks funding for health care law USA Today Share
The GOP-led House voted recently to block funding to implement the nation's health care law. The action came on several amendments to a must-pass spending bill that would pay for government operations from March through September. Specifically, the House voted to prohibit any funds be used by the Internal Revenue Service to carry out the law's mandate that Americans buy health insurance. The individual mandate, one of the law's key tenets, has been struck down by federal courts. More |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
